Cargando…
S230: CD22 CAR T CELL THERAPY IS SAFE AND EFFECTIVE IN PATIENTS WITH LARGE B CELL LYMPHOMA WHO HAVE RELAPSED AFTER CD19 CAR T CELL THERAPY.
| Autores principales: | , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428455/ http://dx.doi.org/10.1097/01.HS9.0000967832.33621.69 |
| _version_ | 1785090473471246336 |
|---|---|
| author | Frank, Matthew J. Baird, John Kramer, Anne Patel, Shabnum Sahaf, Bita Craig, Juliana Crawford, Emma Younes, Sheren Oak, Jean Natkunan, Yasodha Spiegel, Jay Ehlinger, Zachary Chinnasamy, Harshini Reynolds, Warren Srinagesh, Hrishi Su, Yi-Jiun Egeler, Emily Feldman, Steven Mackall, Crystal Muffly, Lori Miklos, David |
| author_facet | Frank, Matthew J. Baird, John Kramer, Anne Patel, Shabnum Sahaf, Bita Craig, Juliana Crawford, Emma Younes, Sheren Oak, Jean Natkunan, Yasodha Spiegel, Jay Ehlinger, Zachary Chinnasamy, Harshini Reynolds, Warren Srinagesh, Hrishi Su, Yi-Jiun Egeler, Emily Feldman, Steven Mackall, Crystal Muffly, Lori Miklos, David |
| author_sort | Frank, Matthew J. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10428455 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104284552023-08-17 S230: CD22 CAR T CELL THERAPY IS SAFE AND EFFECTIVE IN PATIENTS WITH LARGE B CELL LYMPHOMA WHO HAVE RELAPSED AFTER CD19 CAR T CELL THERAPY. Frank, Matthew J. Baird, John Kramer, Anne Patel, Shabnum Sahaf, Bita Craig, Juliana Crawford, Emma Younes, Sheren Oak, Jean Natkunan, Yasodha Spiegel, Jay Ehlinger, Zachary Chinnasamy, Harshini Reynolds, Warren Srinagesh, Hrishi Su, Yi-Jiun Egeler, Emily Feldman, Steven Mackall, Crystal Muffly, Lori Miklos, David Hemasphere Oral Sessions Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10428455/ http://dx.doi.org/10.1097/01.HS9.0000967832.33621.69 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Oral Sessions Frank, Matthew J. Baird, John Kramer, Anne Patel, Shabnum Sahaf, Bita Craig, Juliana Crawford, Emma Younes, Sheren Oak, Jean Natkunan, Yasodha Spiegel, Jay Ehlinger, Zachary Chinnasamy, Harshini Reynolds, Warren Srinagesh, Hrishi Su, Yi-Jiun Egeler, Emily Feldman, Steven Mackall, Crystal Muffly, Lori Miklos, David S230: CD22 CAR T CELL THERAPY IS SAFE AND EFFECTIVE IN PATIENTS WITH LARGE B CELL LYMPHOMA WHO HAVE RELAPSED AFTER CD19 CAR T CELL THERAPY. |
| title | S230: CD22 CAR T CELL THERAPY IS SAFE AND EFFECTIVE IN PATIENTS WITH LARGE B CELL LYMPHOMA WHO HAVE RELAPSED AFTER CD19 CAR T CELL THERAPY. |
| title_full | S230: CD22 CAR T CELL THERAPY IS SAFE AND EFFECTIVE IN PATIENTS WITH LARGE B CELL LYMPHOMA WHO HAVE RELAPSED AFTER CD19 CAR T CELL THERAPY. |
| title_fullStr | S230: CD22 CAR T CELL THERAPY IS SAFE AND EFFECTIVE IN PATIENTS WITH LARGE B CELL LYMPHOMA WHO HAVE RELAPSED AFTER CD19 CAR T CELL THERAPY. |
| title_full_unstemmed | S230: CD22 CAR T CELL THERAPY IS SAFE AND EFFECTIVE IN PATIENTS WITH LARGE B CELL LYMPHOMA WHO HAVE RELAPSED AFTER CD19 CAR T CELL THERAPY. |
| title_short | S230: CD22 CAR T CELL THERAPY IS SAFE AND EFFECTIVE IN PATIENTS WITH LARGE B CELL LYMPHOMA WHO HAVE RELAPSED AFTER CD19 CAR T CELL THERAPY. |
| title_sort | s230: cd22 car t cell therapy is safe and effective in patients with large b cell lymphoma who have relapsed after cd19 car t cell therapy. |
| topic | Oral Sessions |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428455/ http://dx.doi.org/10.1097/01.HS9.0000967832.33621.69 |
| work_keys_str_mv | AT frankmatthewj s230cd22cartcelltherapyissafeandeffectiveinpatientswithlargebcelllymphomawhohaverelapsedaftercd19cartcelltherapy AT bairdjohn s230cd22cartcelltherapyissafeandeffectiveinpatientswithlargebcelllymphomawhohaverelapsedaftercd19cartcelltherapy AT krameranne s230cd22cartcelltherapyissafeandeffectiveinpatientswithlargebcelllymphomawhohaverelapsedaftercd19cartcelltherapy AT patelshabnum s230cd22cartcelltherapyissafeandeffectiveinpatientswithlargebcelllymphomawhohaverelapsedaftercd19cartcelltherapy AT sahafbita s230cd22cartcelltherapyissafeandeffectiveinpatientswithlargebcelllymphomawhohaverelapsedaftercd19cartcelltherapy AT craigjuliana s230cd22cartcelltherapyissafeandeffectiveinpatientswithlargebcelllymphomawhohaverelapsedaftercd19cartcelltherapy AT crawfordemma s230cd22cartcelltherapyissafeandeffectiveinpatientswithlargebcelllymphomawhohaverelapsedaftercd19cartcelltherapy AT younessheren s230cd22cartcelltherapyissafeandeffectiveinpatientswithlargebcelllymphomawhohaverelapsedaftercd19cartcelltherapy AT oakjean s230cd22cartcelltherapyissafeandeffectiveinpatientswithlargebcelllymphomawhohaverelapsedaftercd19cartcelltherapy AT natkunanyasodha s230cd22cartcelltherapyissafeandeffectiveinpatientswithlargebcelllymphomawhohaverelapsedaftercd19cartcelltherapy AT spiegeljay s230cd22cartcelltherapyissafeandeffectiveinpatientswithlargebcelllymphomawhohaverelapsedaftercd19cartcelltherapy AT ehlingerzachary s230cd22cartcelltherapyissafeandeffectiveinpatientswithlargebcelllymphomawhohaverelapsedaftercd19cartcelltherapy AT chinnasamyharshini s230cd22cartcelltherapyissafeandeffectiveinpatientswithlargebcelllymphomawhohaverelapsedaftercd19cartcelltherapy AT reynoldswarren s230cd22cartcelltherapyissafeandeffectiveinpatientswithlargebcelllymphomawhohaverelapsedaftercd19cartcelltherapy AT srinageshhrishi s230cd22cartcelltherapyissafeandeffectiveinpatientswithlargebcelllymphomawhohaverelapsedaftercd19cartcelltherapy AT suyijiun s230cd22cartcelltherapyissafeandeffectiveinpatientswithlargebcelllymphomawhohaverelapsedaftercd19cartcelltherapy AT egeleremily s230cd22cartcelltherapyissafeandeffectiveinpatientswithlargebcelllymphomawhohaverelapsedaftercd19cartcelltherapy AT feldmansteven s230cd22cartcelltherapyissafeandeffectiveinpatientswithlargebcelllymphomawhohaverelapsedaftercd19cartcelltherapy AT mackallcrystal s230cd22cartcelltherapyissafeandeffectiveinpatientswithlargebcelllymphomawhohaverelapsedaftercd19cartcelltherapy AT mufflylori s230cd22cartcelltherapyissafeandeffectiveinpatientswithlargebcelllymphomawhohaverelapsedaftercd19cartcelltherapy AT miklosdavid s230cd22cartcelltherapyissafeandeffectiveinpatientswithlargebcelllymphomawhohaverelapsedaftercd19cartcelltherapy |